JP2023508731A5 - - Google Patents

Info

Publication number
JP2023508731A5
JP2023508731A5 JP2022540595A JP2022540595A JP2023508731A5 JP 2023508731 A5 JP2023508731 A5 JP 2023508731A5 JP 2022540595 A JP2022540595 A JP 2022540595A JP 2022540595 A JP2022540595 A JP 2022540595A JP 2023508731 A5 JP2023508731 A5 JP 2023508731A5
Authority
JP
Japan
Prior art keywords
sequence
seq
rgn
sequence identity
target dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022540595A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023508731A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/067138 external-priority patent/WO2021138247A1/en
Publication of JP2023508731A publication Critical patent/JP2023508731A/ja
Publication of JP2023508731A5 publication Critical patent/JP2023508731A5/ja
Pending legal-status Critical Current

Links

JP2022540595A 2019-12-30 2020-12-28 Rna誘導ヌクレアーゼ、その活性断片および多様体、ならびに使用方法 Pending JP2023508731A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962955014P 2019-12-30 2019-12-30
US62/955,014 2019-12-30
US202063058169P 2020-07-29 2020-07-29
US63/058,169 2020-07-29
PCT/US2020/067138 WO2021138247A1 (en) 2019-12-30 2020-12-28 Rna-guided nucleases and active fragments and variants thereof and methods of use

Publications (2)

Publication Number Publication Date
JP2023508731A JP2023508731A (ja) 2023-03-03
JP2023508731A5 true JP2023508731A5 (cg-RX-API-DMAC7.html) 2024-01-09

Family

ID=74285554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022540595A Pending JP2023508731A (ja) 2019-12-30 2020-12-28 Rna誘導ヌクレアーゼ、その活性断片および多様体、ならびに使用方法

Country Status (8)

Country Link
US (1) US20230203463A1 (cg-RX-API-DMAC7.html)
EP (1) EP4085133A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023508731A (cg-RX-API-DMAC7.html)
CN (1) CN115190912A (cg-RX-API-DMAC7.html)
AU (1) AU2020417760A1 (cg-RX-API-DMAC7.html)
CA (1) CA3163285A1 (cg-RX-API-DMAC7.html)
TW (1) TW202134439A (cg-RX-API-DMAC7.html)
WO (1) WO2021138247A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
JP7890972B2 (ja) 2020-07-15 2026-07-15 ライフ エディット セラピューティクス,インコーポレイティド ウラシル安定化タンパク質並びにその活性断片及びバリアント並びに使用方法
AU2022216614B2 (en) 2021-02-05 2026-03-05 Christiana Care Gene Editing Institute, Inc. Methods of and compositions for reducing gene expression and/or activity
EP4453191A1 (en) 2021-12-23 2024-10-30 Bayer Aktiengesellschaft Novel small type v rna programmable endonuclease systems
IL320573A (en) 2022-11-04 2025-07-01 Life Edit Therapeutics Inc Developed adenine deaminases and RNA-guided nuclease fusion proteins with internal insertion sites and methods of use
WO2024178397A2 (en) 2023-02-24 2024-08-29 Elevatebio Technologies, Inc. Modified immune effector cells and methods of use
CN120826466A (zh) * 2023-04-12 2025-10-21 辉大(上海)生物科技有限公司 靶向vegfa的指导核酸及其用途
WO2025003358A2 (en) * 2023-06-29 2025-01-02 UCB Biopharma SRL Novel nucleic acid targeting systems comprising rna-guided nucleases
TW202617985A (zh) 2024-06-25 2026-05-01 美商生命編輯治療學公司 新穎反轉錄酶及其用途
CN120505294B (zh) * 2025-07-17 2025-09-23 南京诺唯赞生物科技股份有限公司 Rna聚合酶变体及其应用

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9840A (en) 1853-07-12 Improvement in tanning
US699A (en) 1838-04-21 stone
US4217344A (en) 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5380831A (en) 1986-04-04 1995-01-10 Mycogen Plant Science, Inc. Synthetic insecticidal crystal protein gene
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5049386A (en) 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5569597A (en) 1985-05-13 1996-10-29 Ciba Geigy Corp. Methods of inserting viral DNA into plant material
US4774085A (en) 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4853331A (en) 1985-08-16 1989-08-01 Mycogen Corporation Cloning and expression of Bacillus thuringiensis toxin gene toxic to beetles of the order Coleoptera
US5268463A (en) 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
US5608142A (en) 1986-12-03 1997-03-04 Agracetus, Inc. Insecticidal cotton plants
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5039523A (en) 1988-10-27 1991-08-13 Mycogen Corporation Novel Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
KR920701453A (ko) 1989-03-17 1992-08-11 미리엄 디. 멕코나헤이 유전자발현의 외부조절
ES2187497T3 (es) 1990-04-12 2003-06-16 Syngenta Participations Ag Promotores preferentemente en tejidos.
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
AU7979491A (en) 1990-05-03 1991-11-27 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5498830A (en) 1990-06-18 1996-03-12 Monsanto Company Decreased oil content in plant seeds
CA2051562C (en) 1990-10-12 2003-12-02 Jewel M. Payne Bacillus thuringiensis isolates active against dipteran pests
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5399680A (en) 1991-05-22 1995-03-21 The Salk Institute For Biological Studies Rice chitinase promoter
JPH06510187A (ja) 1991-08-27 1994-11-17 ノバルティス アクチエンゲゼルシャフト 同翅類昆虫に対する殺虫性質を有したタンパク質及び植物保護におけるそれらの用法
TW261517B (cg-RX-API-DMAC7.html) 1991-11-29 1995-11-01 Mitsubishi Shozi Kk
US5587308A (en) 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
US5789156A (en) 1993-06-14 1998-08-04 Basf Ag Tetracycline-regulated transcriptional inhibitors
US5814618A (en) 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5608144A (en) 1994-08-12 1997-03-04 Dna Plant Technology Corp. Plant group 2 promoters and uses thereof
US5659026A (en) 1995-03-24 1997-08-19 Pioneer Hi-Bred International ALS3 promoter
US6072050A (en) 1996-06-11 2000-06-06 Pioneer Hi-Bred International, Inc. Synthetic promoters
ES2270227T3 (es) 1998-02-26 2007-04-01 Pioneer Hi-Bred International, Inc. Promotor met-1 del maiz.
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
CN1360632A (zh) 1999-05-04 2002-07-24 孟山都技术有限公司 鞘翅目毒性多肽组合物和抗虫转基因植物
BR0014516A (pt) 1999-09-15 2002-07-02 Monsanto Technology Llc Composições e métodos de uso de delta-endotoxina do bacilo thuringiensis ativo de lepidopteran
US20050183161A1 (en) 2003-10-14 2005-08-18 Athenix Corporation AXMI-010, a delta-endotoxin gene and methods for its use
US7629504B2 (en) 2003-12-22 2009-12-08 Pioneer Hi-Bred International, Inc. Bacillus thuringiensis cry9 nucleic acids
ES2397118T3 (es) 2006-06-14 2013-03-04 Athenix Corporation AXMI-031, AXMI-039 ,AXMI-040 y AXMI-049, una familia de genes de endotoxina delta y métodos para su uso
ES2738980T3 (es) 2008-09-15 2020-01-28 Childrens Medical Ct Corp Modulación de BCL11A para el tratamiento de hemoglobinopatías
CN102648281B (zh) 2009-07-02 2017-04-05 阿森尼克斯公司 Axmi‑205杀虫基因和它的使用方法
US8586832B2 (en) 2009-12-21 2013-11-19 Pioneer Hi Bred International Inc Bacillus thuringiensis gene with Lepidopteran activity
CN103154247A (zh) 2010-08-19 2013-06-12 先锋国际良种公司 对鳞翅目昆虫具有活性的新苏云金杆菌基因
US9405700B2 (en) 2010-11-04 2016-08-02 Sonics, Inc. Methods and apparatus for virtualization in an integrated circuit
HUE051612T2 (hu) 2012-07-11 2021-03-01 Sangamo Therapeutics Inc Eljárások és készítmények lizoszomális tárolási betegségek kezelésére
US8697359B1 (en) * 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
CN105517579B (zh) * 2013-07-10 2019-11-15 哈佛大学校长及研究员协会 用于RNA向导的基因调节和编辑的正交Cas9蛋白
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
US10450584B2 (en) 2014-08-28 2019-10-22 North Carolina State University Cas9 proteins and guiding features for DNA targeting and genome editing
MX2017014560A (es) * 2015-05-15 2018-03-01 Pioneer Hi Bred Int Caracterizacion rapida de sistemas de endonucleasa cas, secuencias pam y elementos arn de guia.
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
EP4159848A1 (en) * 2015-12-29 2023-04-05 Monsanto Technology LLC Novel crispr-associated transposases and uses thereof
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
CA3038982A1 (en) * 2016-09-30 2018-04-05 The Regents Of The University Of California Rna-guided nucleic acid modifying enzymes and methods of use thereof
WO2019046703A1 (en) * 2017-09-01 2019-03-07 Novozymes A/S METHODS OF ENHANCING GENOME EDITION IN FUNGI
US20200354419A1 (en) * 2017-11-03 2020-11-12 Hunterian Medicine Llc Compositions and methods of use thereof for the treatment of duchenne muscular dystrophy
US20210172008A1 (en) * 2018-04-04 2021-06-10 Lifeedit, Inc. Methods and compositions to identify novel crispr systems
AU2019282149B2 (en) * 2018-06-05 2025-08-21 Life Edit Therapeutics, Inc. RNA-guided nucleases and active fragments and variants thereof and methods of use
WO2020028729A1 (en) 2018-08-01 2020-02-06 Mammoth Biosciences, Inc. Programmable nuclease compositions and methods of use thereof
US20220096543A1 (en) 2018-12-24 2022-03-31 Virgina Tech Intellectual Properties, Inc. Tollip deficient neutrophils and uses thereof

Similar Documents

Publication Publication Date Title
US11802277B2 (en) Thermostable Cas9 nucleases
US20220033858A1 (en) Crispr oligoncleotides and gene editing
KR102382772B1 (ko) 화학적으로 변형된 가이드 rna를 사용하는 고 특이성 게놈 편집
JP7099724B2 (ja) 規定された配列および長さのdna1本鎖分子の拡大可能な生物工学的生成
Knapp et al. Transcription and processing of intervening sequences in yeast tRNA genes
CN103911376A (zh) CRISPR-Cas9靶向敲除乙肝病毒cccDNA及其特异性sgRNA
WO2017190664A1 (zh) 化学合成的crRNA和修饰crRNA在CRISPR/Cpf1基因编辑系统中的应用
CN104520429B (zh) 通过Cas9-crRNA复合物的RNA指导的DNA裂解
US20220298494A1 (en) Enzymes with ruvc domains
US12435323B2 (en) Enzymes with RUVC domains
EP4159853A1 (en) Genome editing system and method
US20220333129A1 (en) A nucleic acid delivery vector comprising a circular single stranded polynucleotide
US20220389418A1 (en) Rna-guided cas nucleases and uses thereof in diagnostics and therapy
CN116694603A (zh) 新型的Cas蛋白、Crispr-Cas系统及其在基因编辑领域中的用途
WO2017215517A1 (zh) 测序文库构建中5'和3'接头连接副产物的去除方法
CN118006584A (zh) CRISPR基因座完全缺失Cas1、Cas2和Cas4的可编程核酸酶及其应用
CN105602972B (zh) 基于CRISPR-Cas9体外改造腺病毒载体的方法
US12612657B2 (en) Extrachromosomal DNA labeling
US20240360477A1 (en) Systems and methods for transposing cargo nucleotide sequences
CN121737128A (zh) 一种提高环状rna稳定性的序列优化方法及应用和产品
CA3026372C (en) High specificity genome editing using chemically modified guide rnas
WO2024244000A1 (zh) 一种工程改造的sgRNA设计及制备方法
CA2989084C (en) Thermostable cas9 nucleases
CA2957441C (en) Genome editing using campylobacter jejuni crispr/cas system-derived rgen
CN121717913A (zh) 一种腺嘌呤单碱基编辑系统及其应用